PRODUCT CLASSIFICATION
產品分類Ark Pharm雜環類化合物,硼酸及其衍生物
Ark Pharm, Inc.是一家位于美國伊利諾斯州的制藥公司,專注于雜環類產品的研發和生產,產品線包括雜環類化合物,硼酸及其衍生物,有機模塊產品和手型切塊產品,產品種類已達 50000種,現貨產品已超過20000種,約4,000種為du有產品。
?成立于2007年,它是為制藥公司、大學、生物技術公司、醫療保健行業以及合同研究機構等提供研究化學領域的先進供應商。Ark Pharm, Inc. 的業務范圍包括提供超過35,000種化合物,并不斷添加新產品到其產品目錄中。公司還進行批量生產、采購和分銷。其產品種類廣泛,包括積木、先進的中間體、氨基酸和多肽、催化劑和配體、天然產物、核苷、核苷酸等。憑借其化學專業知識和經濟制造能力,Ark Pharm, Inc. 能夠按時向客戶提供具有競爭力的高質量產品。
Ark Pharm品牌部分產品訂購信息,如需其他產品請聯系本店客服:
貨號 | 產品名稱 | 規格 |
AK-77977 | 5-Iodo-7H-pyrrolo[2,3-d]pyrimidine | 1g |
AK-77977 | 5-Iodo-7H-pyrrolo[2,3-d]pyrimidine | 250mg |
AK-77977 | 5-Iodo-7H-pyrrolo[2,3-d]pyrimidine | 5g |
AK-86040 | Dicyclohexyl(2',6'-diisopropoxy- [1,1'-biphenyl]-2-yl)phosphine | 10g |
AK-86040 | Dicyclohexyl(2',6'-diisopropoxy- [1,1'-biphenyl]-2-yl)phosphine | 1g |
AK-86040 | Dicyclohexyl(2',6'-diisopropoxy- [1,1'-biphenyl]-2-yl)phosphine | 25g |
AK-86040 | Dicyclohexyl(2',6'-diisopropoxy- [1,1'-biphenyl]-2-yl)phosphine | 5g |
AK160980 | Empagliflozin | 10g |
AK160980 | Empagliflozin | 1g |
AK160980 | Empagliflozin | 5g |
AK-24882 | 6-Bromopyrido[2,3-d]pyrimidin-4(1H)-one | 100mg |
AK-24882 | 6-Bromopyrido[2,3-d]pyrimidin-4(1H)-one | 1g |
AK-24882 | 6-Bromopyrido[2,3-d]pyrimidin-4(1H)-one | 250mg |
AK-27788 | 2,6-Dichloro-4-methylpyridin-3-amine | 1g |
AK122332 | 2-((4-Hydroxyphenyl)sulfonyl)phenol | 1g |
AK-24882 | 6-Bromopyrido[2,3-d]pyrimidin-4(1H)-one | 5g |
AK122332 | 2-((4-Hydroxyphenyl)sulfonyl)phenol | 5g |
AK-46818 | Methyl 4-nitro-1H-pyrazole-3-carboxylate | 10g |
AK141300 | 3-Fluoro-2-(fluoromethyl)-2-methylpropanoic acid | 1g |
AK-46818 | Methyl 4-nitro-1H-pyrazole-3-carboxylate | 5g |
AK162039 | (R)-Morpholine-3-carboxylic acid hydrochloride | 1g |
AK-44682 | 3-(Bromomethyl)pyridine hydrobromide | 5g |
AK-44682 | 3-(Bromomethyl)pyridine hydrobromide | 25g |
AK-27788 | 2,6-Dichloro-4-methylpyridin-3-amine | 250mg |
AK-27788 | 2,6-Dichloro-4-methylpyridin-3-amine | 5g |
AK141300 | 3-Fluoro-2-(fluoromethyl)-2-methylpropanoic acid | 100mg |
AK-44682 | 3-(Bromomethyl)pyridine hydrobromide | 100g |
AK141300 | 3-Fluoro-2-(fluoromethyl)-2-methylpropanoic acid | 250mg |
AK162039 | (R)-Morpholine-3-carboxylic acid hydrochloride | 5g |
AK122332 | 2-((4-Hydroxyphenyl)sulfonyl)phenol | 10g |
AK-46818 | Methyl 4-nitro-1H-pyrazole-3-carboxylate | 1g |
AK-46818 | Methyl 4-nitro-1H-pyrazole-3-carboxylate | 25g |
AK-46818 | Methyl 4-nitro-1H-pyrazole-3-carboxylate | 100g |
AK-44682 | 3-(Bromomethyl)pyridine hydrobromide | 10g |
AK198650 | 2-(1-(Methylsulfonyl)cyclopropyl)acetic acid | 100mg |
AK188521 | (S)-1,5-Dimethylpiperazin-2-one hydrochloride | 250mg |
AK-77977 | 5-Iodo-7H-pyrrolo[2,3-d]pyrimidine | 10g |
AK199207 | 6-(Bromomethyl)quinoline hydrobromide | 250mg |
AK198650 | 2-(1-(Methylsulfonyl)cyclopropyl)acetic acid | 250mg |
AK199207 | 6-(Bromomethyl)quinoline hydrobromide | 5g |
AK-27788 | 2,6-Dichloro-4-methylpyridin-3-amine | 25g |
AK188522 | (R)-1,5-Dimethylpiperazin-2-one hydrochloride | 5g |
AK162039 | (R)-Morpholine-3-carboxylic acid hydrochloride | 10g |
AK199207 | 6-(Bromomethyl)quinoline hydrobromide | 1g |
AK188522 | (R)-1,5-Dimethylpiperazin-2-one hydrochloride | 1g |
AK198650 | 2-(1-(Methylsulfonyl)cyclopropyl)acetic acid | 1g |
AK188536 | Diethyl 2-(methylamino)malonate hydrochloride | 250mg |
AK162039 | (R)-Morpholine-3-carboxylic acid hydrochloride | 25g |
AK198650 | 2-(1-(Methylsulfonyl)cyclopropyl)acetic acid | 5g |
AK188031 | Methotrexate hydrate(1:x) | 5g |
AK-44682 | 3-(Bromomethyl)pyridine hydrobromide | 1g |
AK160980 | Empagliflozin | 25g |
AK188031 | Methotrexate hydrate(1:x) | 1g |
AK199167 | Spiro[isochroman-1,4'-piperidine] 2,2,2-trifluoroacetate | AK188522 |
AK188522 | (R)-1,5-Dimethylpiperazin-2-one hydrochloride | 250mg |
AK188536 | Diethyl 2-(methylamino)malonate hydrochloride | 1g |
AK188521 | (S)-1,5-Dimethylpiperazin-2-one hydrochloride | 1g |
AK188536 | Diethyl 2-(methylamino)malonate hydrochloride | 5g |
AK-27788 | 2,6-Dichloro-4-methylpyridin-3-amine | 10g |
AK173239 | Ethyl 7-methyl-2,3-dihydro-1H-indene-4-carboxylate | 100g |